St. Jude AF suppression trial
This article was originally published in The Gray Sheet
Executive Summary
Enrollment has begun for a randomized trial to measure the efficacy of a new atrial fibrillation suppression algorithm in cardiac resynchronization therapy, the St. Paul, Minn. firm announces Nov. 17. Because atrial fibrillation can potentially inhibit delivery of CRT, the study will help St. Jude better understand the benefit of implantable cardioverter defibrillators that include the AF-suppression technology. The algorithm suppresses atrial fibrillation by dynamically overdriving ICD stimulation in response to patient activity...